3
Announcements
Trials
Browse
Landscape
Status
Completed
12
Recruiting
4
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
29
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Metastatic Hormone-sensitive Prostate Cancer
1
Interventions
Surveys and Questionnaires
39
Blood Specimen Collection
23
Specimen Handling
14
Radiotherapy
12
Surgical Procedures, Operative
10
Magnetic Resonance Spectroscopy
10
Interviews as Topic
10
Observation
9
Drug Therapy
9
Data Collection
8
Immunotherapy
7
Watchful Waiting
5
Tomography, X-Ray Computed
5
Radiosurgery
5
Nivolumab
5
Mental Status and Dementia Tests
5
Mastectomy, Segmental
5
Immune Checkpoint Inhibitors
5
Biopsy
5
ribociclib
4
palbociclib
4
lorlatinib
4
Therapeutics
4
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Ipilimumab
4
High-Throughput Nucleotide Sequencing
4
Hepatectomy
4
Echocardiography
4
Bevacizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
apalutamide
×
Clear all
NCT05901649
2026-05-08
ArtemisPRO
Janssen-Cilag Ltd.
Active not recruiting
504 enrolled